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Abstract
FUMzyme® is an enzyme-based feed additive intended to degrade fumonisin mycotoxins found as
contaminants in feeds for avian species. It is produced from a genetically modiﬁed strain of
Komagataella pastoris. The additive is already authorised for use with pigs. During the course of this
assessment, it was shown that the production strain and its recombinant genes are not present in the
ﬁnal product. Safety for the consumer, the user and the environment were also established. The
extension of its use to all avian species is not expected to alter these conclusions. Chickens and turkeys
for fattening and laying hens showed no adverse effect when given feed containing 100 times the
maximum recommended dose. Consequently, the EFSA Panel on Additives and Products or Substances
used in Animal Feed (FEEDAP) concludes that the additive is safe for poultry when used within the dose
range proposed (15–300 U/kg feed) and extends this conclusion to all other avian species. Five short-
term feeding studies were made in which poultry were given feed contaminated with fumonisins with or
without the additive. Each included a measure of the concentration of fumonisin B1 and its breakdown
products and showed that the enzyme was able to signiﬁcantly reduce the concentration of fumonisin in
faeces and various points in the digestive tract and increase the concentration of the degradation
products. In addition, ratio of sphinganine/sphingosine, considered the most sensitive endpoint for
fumonisin toxicosis, was signiﬁcantly reduced by the addition of FUMzyme® at the minimum proposed
dose, when added to diets contaminated with fumonisins. FUMzyme® has the capacity to degrade
fumonisins in feed, at concentrations below the Guidance limits operating in the EU in chickens and
turkeys for fattening and laying hens at the minimum recommended dose of 15 U/kg complete feed. This
conclusion can be extrapolated to all avian species.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Biomin GmbH2 for authorisation of the product
fumonisin esterase (FUMzyme®), when used as a feed additive for all avian species (category:
technological additives; functional group: substances for reduction of the contamination of feed by
mycotoxins).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 19 February 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the
safety for the target animals, consumer, user and the environment and on the efﬁcacy of the product
fumonisin esterase (FUMzyme®), when used under the proposed conditions of use (see Section 3.2).
1.2. Additional information
FUMzyme is an enzyme-based additive intended to degrade fumonisin mycotoxins found as
contaminants of feed. The safety and efﬁcacy of the additive when used in feed to pigs was the
subject of an opinion published in 2014 (EFSA FEEDAP Panel, 2014). This opinion considered the fact
that the enzyme is produced by a genetically modiﬁed (GMM) strain of Komagataella pastoris.
However, since the production organism and its recombinant DNA could not be detected in the ﬁnal
product, it was concluded that the additive did not give rise to any safety concern with regard to the
genetic modiﬁcation of the production strain. Evidence was also available showing that the additive
was safe for use with pigs at the proposed dose and that its use in animal production did not give rise
to concerns for the consumer of animal products, for users of the additive or for the environment. It
was also shown that metabolites of fumonisin produced by the action of the enzyme have a lower
toxicity than the parent mycotoxin. Subsequent to this opinion, the additive was authorised for use in
feed for pigs and is included in the European Union (EU) Register of Feed Additives (1m03).3 The
applicant is now seeking authorisation for use of the same additive with all avian species.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of FUMzyme® as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20085, and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Biomin GmbH, Industriestrabe 21, 3130 Herzogenburg, Austria.
3 Commission implementing Regulation (EU) No 1115/2014 of 21 October 2014 concerning the authorisation of a preparation of
fumonisin esterase produced by Komagataella pastoris (DSM 26643) as a feed additive for pigs. OJ L 302, 22.10.2014, p. 51.
4 FEED dossier reference: FAD-2014-0040.
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
application.6
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of FUMzyme® is
in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on technological additives (EFSA FEEDAP Panel, 2012a) and Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011).
3. Assessment
The use of a GMM for the production of the additive has been previously assessed and safety for
consumers, users and the environment established. Extension of use to the additional species under
application is not expected to alter these conclusions. Consequently, this opinion focuses on the safety
and efﬁcacy of the additive when used in feed for the additional target species.
3.1. Characterisation
The additive which is the subject of the present application has the same formulation and method of
manufacture as that considered in the previous opinion for pigs (EFSA FEEDAP Panel, 2014). Thus, the
data pertaining to impurities, physical properties and shelf life still apply. The data on stability in vitamin–
mineral premixes and feed for pigs for fattening and evidence that the additive is capable of
homogeneous mixing in feed are considered applicable to poultry given the similarity in feed formulation.
3.2. Conditions of use
FUMzyme® is intended for use in feed for all avian species at a minimum dose of 15 units of
enzyme activity (U)/kg complete feed and a maximum of 300 U/kg complete feed. It can be added
directly to feed or via premixtures. No withdrawal period is proposed.
3.3. Safety
3.3.1. Safety for the target species
3.3.1.1. Chickens for fattening
A tolerance trial was made with 600 mixed-sex 1-day old Ross 308 birds distributed to one of three
treatment groups.7 These were a control group given a maize–soybean mash diet, a group given the
same diet supplemented with FUMzyme at 300 U/kg complete feed (19 maximum recommended dose)
and an overdose group given the same diet supplemented with 30,000 U/kg complete feed (1009). The
concentration of enzyme in the diets was conﬁrmed by analysis and fumonisin B1 and B2 were absent
(limit of detection (LOD) 25 lg/kg).8 The duration of the trial was 35 days. The study followed a
randomised complete block design with 10 pens of 20 birds used for each treatment group. Daily
observations were made of health and mortality was recorded. Individual weight was measured at the
start, on days 14 and 28, and at the end of the trial at 35 days. Feed intake per pen was recorded. From
this data, weight gain, daily weight gain and the feed to gain ratio of each pen were calculated.
Data were ﬁrst checked for normal distribution by the Shapiro–Wilk test. Where data was not
normally distributed, data were compared by a Kruskal–Wallis test (non-parametric analysis of variance
(ANOVA) for more than two samples) including pairwise comparisons. Otherwise, data were compared
by ANOVA including tests for homogeneity of variances (Levene’s test). Where variances were
homogeneous, ANOVA was followed up with Bonferroni test for multiple comparisons. Where variances
were not homogeneous, ANOVA was substituted by Welch Test and followed up by Tamhane’s T2 test
for multiple comparisons. A power calculation was made. Pen was considered the experimental unit for
the statistical analysis.
6 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports/fad-2013-
0002?search&form-return
7 Technical dossier/Supplementary Information March 2016/Section III/Annex (i) 01.
8 Technical dossier/Supplementary Information March 2016/Section III/Annex (i) 06.
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Overall mortality was around 5% with no signiﬁcant differences between groups. Feed to gain ratio
(between 1.75 and 1.82) and feed intake (between 3.0 and 3.2 kg/bird) also did not differ signiﬁcantly
between groups. There was a signiﬁcant increase in ﬁnal body weight in the group treated with 300 U/kg
FUMzyme (1.87 kg) compared to either the control group (1.77 kg) or the 1009 overdose group
(1.75 kg). However, the difference between the control and 1009 overdose groups was not signiﬁcant.
3.3.1.2. Turkeys for fattening
A total of 720 one-day-old female BUT 10 turkey pullets were assigned to either a control group, a
group given FUMzyme at an intended dose of 300 U/kg (19) or an overdose group given an intended
dose of 30,000 U/kg (1009).9 However, analysis of the diets showed that the enzyme addition was
higher than intended (490 and 560 for the lower dose group and 40,000 and 50,000 U/kg for the
overdose group). Each treatment consisted of 16 replicates of 15 animals. Animals were given a basal
diet based on wheat and soybean meal in mash form and were fed for a total of 42 days. Diets were
free from fumonisin B1 and B2 (LOD 20 lg/kg feed).
Birds were monitored for health and mortality was recorded. Weights were taken on days 0, 21 and
42, and intake recorded on days 21 and 42. From this data, daily weight gain and feed to gain ratio
were calculated. Results obtained were subjected to ANOVA and the Tukey’s test was used to compare
means between treatments. Pen means were the units for statistical analysis.
Overall mortality was low (1.8%). No signiﬁcant differences in ﬁnal body weight (~2.1 kg) or total
feed intake (3.5 kg/bird) were found between treatments. The calculated feed to gain ratio did not
differ between the control and 300 U/kg group (1.79–1.78) but a signiﬁcant improvement in feed to
gain ratio was recorded for the overdose group compared to the control group (1.68 vs 1.79).
3.3.1.3. Laying hens
In this trial, 780 laying hens (Novobrown) at the start of their laying period were assigned to the
same three treatment groups as in the trials above.10 The start of the experiment, when hens were
140 days of age, was preceded by a 7-day acclimatisation period. Eggs produced during this period
were discarded. The intended dose of FUMzyme was conﬁrmed by analysis of the feed. Birds were
housed in pens of 13 birds with each pair of pens representing one replicate. In total, there were 10
replicates per treatment. Birds were fed a basal diet of wheat/sunﬂower cake and soybean meal in
mash form and the duration of the trial was 58 days.
Mortality, feed consumption and egg production was monitored throughout the study, average egg
size measured at two-week intervals and body weight recorded at the start and end of the experiment
and when birds were 168 days of age. Feed intake to egg mass was calculated. Egg quality
parameters (individual egg weights, shell strength and Haugh units) were determined for all eggs
produced when birds were 140, 168 and 198 days of age. Results were subjected to ANOVA after
normality of data and evenness of variance conﬁrmed (Shapiro and Bartlett tests). The experimental
unit was either the paired pens or the eggs depending on the parameters evaluated.
Mortality over the experimental period was low (0.3%). The overall laying rate was 91.7%, average
egg weight 54.7 g, egg mass/hen 2.9 kg and the feed to egg mass ratio was 2.08. No signiﬁcant
differences between treatments were recorded for any parameter after the start of the experiment.
3.3.2. Conclusions on safety for the target species
Chickens for fattening, turkeys for fattening and laying hens showed no adverse effects when
FUMzyme was included in diets at a 100-fold higher inclusion rate than the maximum recommended
dose. Consequently, the FEEDAP Panel concludes that FUMzyme is safe for chickens, turkeys and
laying hens at the maximum recommended dose of 300 U/kg complete feed.
Since a wide margin of safety has been demonstrated in two poultry species covering both growth
and reproduction, this conclusion can be extended to all avian species when given diets containing
FUMzyme containing a maximum of 300 U/kg complete feed without a need for further studies.
3.3.3. Safety for the consumer
Toxicological studies, including tests for genotoxicity and a subchronic oral toxicity study, were
assessed in the context of the previous application for the use of FUMzyme with pigs. No concerns
9 Technical dossier/Supplementary Information March 2016/Section III/Annex (ii) 07-11.
10 Technical dossier/Supplementary Information March 2016/Section III/Annex (ii) 01-06.
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about the toxicity of the enzyme or any residual material carried over from its production were
identiﬁed. Similarly, the metabolites resulting from the complete or partial de-esteriﬁcation of
fumonisins were also assessed for safety and found to be less toxic than the parent mycotoxin. Since
the action of FUMzyme on any contaminating fumonisins will be essentially the same in the pig and
avian digestive tracts, the conclusion on safety for the consumer following the use of the additive with
pigs also applies to its use with avian species.
3.4. Efﬁcacy
3.4.1. Enzyme speciﬁcity
A number of in vitro studies made with fumonisin B1 considered in the previous opinion (EFSA
FEEDAP Panel, 2014) showed that the action of FUMzyme resulted in partial or complete
de-esteriﬁcation, releasing tricarballylic acid (TCA) and the fully or partially de-esteriﬁed aminopentol
backbone. Although fumonisin B1 and B2 are the most prevalent fumonisins, a total of eight are
recognised (Soriano and Dragacci, 2004). These differ by the number and position of hydroxyl groups
on the aminopentol backbone. However, since all fumonisins possess tricarballylic substituents on
carbons 6 and 7 and since the presence of the hydroxyls are insufﬁciently bulky to affect enzyme
binding or catalytic activity, FUMzyme is considered equally effective in its action against all recognised
fumonisins.
3.4.2. Efﬁcacy in poultry
A total of ﬁve short-term (14 days) in vivo studies made with chickens, turkeys for fattening or
laying hens were provided in support of the efﬁcacy of FUMzyme® in poultry.
Each study consisted of a group of birds given a basal diet essentially free of fumonisin, a group given
feed artiﬁcially contaminated with fumonisin B1 and a third group given the contaminated feed
supplemented with FUMzyme. Artiﬁcial contamination resulted in concentrations of fumonisin of
10–20 mg/kg feed, at or below the maximum level given by Commission Recommendation 2006/576/EC
(20 mg/kg complete feed for poultry).
In all ﬁve studies, the concentration of fumonisin B1 (FB1) and its metabolites (hydrolysed
fumonisin B1 (HFB1) and partially hydrolysed fumonisin B1 (pHFB1)) were analysed in excreta.
Additionally, in two of the chicken studies (studies 1 and 2), FB1 and its metabolites were monitored
at various points in the digestive tract. Excreta and digesta samples were taken on the last day of
the trial. In the second study with chicken and in the study with turkeys, the ratio of sphinganine/
sphingosine (Sa/So) in plasma and/or liver was also monitored.
Studies 111 and 212 were done at the same location with a similar design. The ﬁrst involved 96 and
the second 108 one-day-old male Ross 708 chicks; both given 7 days acclimatisation before the start
of the trial. In study 1, each treatment was replicated eight times with four birds per replicate, and in
study 2, six replicates of six birds were used. FUMzyme was applied at 250 U/kg feed in study 1 and
75 U/kg in study 2. Concentration of FB1 and its metabolites in excreta and the digestive tract were
analysed by ANOVA after a normal distribution was conﬁrmed followed by a post-hoc Tukey’s test.
The third study13 involving chickens for fattening used 75 mixed-sex 1-day-old Ross 308 birds,
10 days of age at the start of the trial. There were ﬁve replicates of ﬁve birds per treatment. FUMzyme
was applied at the minimum recommended dose of 15 U/kg feed. Comparisons of values for analysed
parameters were made using a Student’s t-test or Mann–Whitney test depending on the normality of
distribution.
Study 414 was made with 15 individually housed female turkeys (Hybrid Converter), 10-week-old at
the start of the study. Five birds were allocated to each treatment and FUMzyme was applied to feed
at the minimum recommended dose of 15 U/kg feed. In this study, in addition to the concentration of
fumonisin B1 and its metabolites in excreta and the digestive tract, the analyses of Sa/So in serum
was done by ANOVA preceded by Kolmogorov–Smirnov test for normal distribution and Levene’s test
for homogeneity of variances. ANOVA was followed up with post-hoc Bonferroni test. When
11 Technical dossier/Section IV/Annex IV_03-08.
12 Technical dossier/Section IV/Annex IV_09-16.
13 Technical dossier/Section IV/Annex IV_28-38.
14 Technical dossier/Section IV/Annex IV_17-27.
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comparisons of only two groups were carried out, Student’s t-test (normally distributed) or
Mann–Whitney test (not normally distributed) were used.
The ﬁfth study15 was made with 120 laying hens (Lohmann Brown), 22 weeks of age at the start of
the study. There were 10 replicates of four birds per pen allocated to each treatment and faeces were
collected at the start and on days 7 and 14. FUMzyme was added at the minimum recommended dose
of 15 U/kg feed. FB1 (day 7 and day 14) and pHFB1a (day 7) were compared by Kruskal–Wallis test
(all groups), followed by pairwise comparison, for the rest of the parameters the contaminated diet
was compared to the contaminated diet plus FUMzyme by Student’s t-Test.
Results of the analysis of FB1 and its degradation products in faecal samples collected at the end of
each study are shown in Table 1.
The results of all ﬁve studies show a common pattern in which > 50% of fumonisin B1 seen in the
faeces of birds given the contaminated diet is degraded to the partially or fully de-esteriﬁed hydrocarbon
backbone. The results also suggest that the hydrolysis of the TCA linked to carbon 6 is favoured over that
linked to carbon 7. In studies 1 and 2, where samples were also taken from the gizzard, upper small
intestine (duodenum/mid-jejunum) and lower small intestine (mid-jejunum/ileum), the pattern of
degradation was also the same and the differences between the contaminated feed with and without
FUMzyme addition signiﬁcant. The relatively high values seen for the partially hydrolysed fumonisin seen
in laying hens given the contaminated feed implies some natural capacity for degradation.
The ratio of sphinganine/sphingosine (Sa/So) is the most sensitive endpoint for fumonisin toxicosis.
Two of the four studies (study 2 in chickens for fattening and study 4 in turkeys for fattening) included
this biomarker. In study 2, both the liver and serum taken at the end of the trial were analysed, while
in study 4, only serum samples were taken. The Sa/So ratios found in the two studies are shown in
Table 2.
Table 1: Average concentration of fumonisin B1 (FB1) and its degradation products (HFB1:
hydrolysed fumonisin B1; pHFB1a and b: partially hydrolysed fumonisin B1) in faeces of
poultry (lg/g faeces) after 14 days
Study No,
animal (dose)
Parameters
Treatment group p value
Uncontaminated
diet
Contaminated
diet (x)
Contaminated diet +
Fumzyme (y)
x vs y
Study 1 chickens
(250 U/kg)
FB1 0.35 4.27 1.32 < 0.001
pHFB1a 0.06 0.06 0.06 –
pHFB1b 0.05 0.13 0.67 0.003
HFB1 0.05 0.09 0.49 0.007
Study 2 chickens
(75 U/kg)
FB1 0.19 5.75 2.23 < 0.001
pHFB1a 0.08 0.10 0.29 0.006
pHFB1b 0.08 0.12 1.32 < 0.001
HFB1 0.05 0.05 1.24 0.002
Study 3 chickens
(15 U/kg)
FB1 0.20 4.87 2.34 0.001
pHFB1a 0.05 0.17 0.20 ns
pHFB1b 0.05 0.20 1.13 0.008
HFB1 0.05 0.05 1.29 0.008
Study 4 turkeys
(15 U/kg)
FB1 0.20 5.24 1.19 0.002
pHFB1a 0.02 0.02 0.02 –
pHFB1b 0.02 0.02 0.41 0.054
HFB1 0.06 0.06 1.65 0.005
Study 5 hens
(15 U/kg)
FB1 0.11 8.05 3.45 ns
pHFB1a 0.01 1.19 0.75 ns
pHFB1b 0.01 2.35 1.89 ns
HFB1 0.02 0.57 4.44 < 0.001
––: Values < limit of detection (LOD), statistics no calculated.
15 Technical dossier/Supplementary Information March 2016/Annex (iii) 01-11.
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As it can be seen, in both studies, poultry receiving the contaminated feed had a signiﬁcantly higher
Sa/So ratio compared to birds given the feed free from fumonisins. Addition of FUMzyme® to
contaminated feed signiﬁcantly reduced the Sa/So values, but not to the level seen in the uncontaminated
control.
3.4.3. Conclusions on efﬁcacy for the target species
FUMzyme® has the capacity to degrade fumonisins in feed. This was shown at fumonisins
concentrations in feed below the Guidance limits operating in the EU in chickens and turkeys for
fattening and laying hens at the minimum recommended dose of 15 U/kg complete feed. This
conclusion can be extrapolated to all avian species without the need for further studies.
4. Conclusions
The use of the additive in feed for pigs has been previously assessed and safety for consumers,
users and the environment established. Extension of use to all avian species is not expected to alter
these conclusions.
FUMzyme is safe for chickens, turkeys and laying hens at the maximum recommended dose of
300 U/kg complete feed. Since a wide margin of safety has been demonstrated in two poultry species
covering both growth and reproduction, this conclusion can be extended to all avian species when fed
diets containing FUMzyme containing a maximum of 300 U/kg complete feed.
FUMzyme® has the capacity to degrade fumonisins in feed. This was shown at fumonisins
concentrations in feed below the Guidance limits operating in the EU in chickens and turkeys for
fattening and laying hens at the minimum recommended dose of 15 U/kg complete feed. This
conclusion can be extrapolated to all avian species.
Documentation provided to EFSA
1) FUMzyme® (fumonisin esterase). December 2014. Submitted by Biomin GmbH.
2) FUMzyme® (fumonisin esterase). Supplementary information March 2016. Submitted by
Biomin GmbH.
3) Comments from the Member States.
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Table 2: Sphinganine/sphingosine (Sa/So) ratio in serum and liver samples
Study No and
animal
Tissue
Sa/So ratio P value
Uncontaminated
diet
Contaminated
diet (x)
Contaminated diet +
Fumzyme (y)
x vs y
Study 2 chickens Serum 0.11 0.20 0.16 0.003
Liver 0.11 0.28 0.18 0.037
Study 4 turkeys Serum 0.16 0.24 0.19 0.016
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GMM Genetically modiﬁed microorganism
LOD limit of detection
Sa sphinganine
So sphingosine
TCA tricarballylic acid
U units of enzyme activity
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